scanX
Eris Lifesciences
add_icon

Eris Lifesciences

1,361.40
+7.90
(0.58%)
Market Cap
18,861.20 Cr
PE Ratio
29.13
Volume
1,05,765.00
Day High - Low
1,370.00 - 1,323.10
52W High-Low
1,910.00 - 1,200.00
ann
Company has added their latest Transcript14 hrs ago
Viewcross
right
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
18,861.20 Cr
EPS
45.33
PE Ratio
29.13
PB Ratio
4.83
Book Value
281.64
EBITDA
1,088.34
Dividend Yield
0.53 %
Industry
Healthcare
Sector
Pharmaceuticals
Return on Equity
11.45
Debt to Equity
0.97
Analyst Rating and Forecast
- By Refinitiv from10 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+90.00 %
+90.00 %
Hold
Hold+10.00 %
+10.00 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
positive
Eris appoints Vineet Varma as Independent Director1 day ago
Shareholders approved the appointment of Mr. Vineet Varma as an Independent Director through a postal ballot process. The resolution received 99.92% of votes in favour.
neutral
Eris to meet Franklin Templeton1 day ago
Eris Lifesciences Limited management will meet Franklin Templeton on May 29, 2026. The virtual interaction will be led by Mr. Krishnakumar Vaidyanathan.
neutral
Eris Lifesciences posts Q4FY26 call recording6 days ago
Eris Lifesciences Limited has released the recording of its earnings conference call for Q4FY26. The call discussed audited results for the quarter and year ended March 31, 2026.
View more

Peer Comparison Compare Peers on Screener

Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
Sun Pharmaceutical
1,840.80
#1 4,41,669.60
38.37
#1 58,220.10
6.38
#1 11,565
25.80
54.06
Divis Laboratories
6,753.00
1,79,270.90
69.82
10,560.00
8.73
2,520
13.44
57.07
Torrent Pharmaceuticals
4,452.10
1,50,679.30
70.46
13,753.00
19.18
2,028
-26.91
56.43
Cipla
1,417.50
1,14,502.90
29.64
27,711.70
-2.46
3,783
-55.32
64.74
Dr Reddys Laboratories
1,327.90
1,10,832.20
26.69
33,593.30
-0.44
3,998
-86.05
56.54
Zydus Life Science
1,079.05
1,08,577.70
21.19
26,719.70
13.65
5,242
7.82
74.62
Lupin
2,266.00
1,03,566.00
#1 19.33
27,487.50
19.98
5,345
#1 87.72
45.18
Mankind Pharma
2,423.60
1,00,047.40
51.52
14,277.60
12.03
1,750
31.75
55.67
Aurobindo Pharma
1,461.20
84,866.70
24.27
33,384.70
3.21
3,376
1.99
52.40
Laurus Labs
1,373.90
74,170.90
83.31
6,812.90
#1 21.03
884
21.18
80.00
Growth Rate
Revenue Growth
6.97 %
Net Income Growth
28.40 %
Cash Flow Change
119.13 %
ROE
-7.06 %
ROCE
11.27 %
EBITDA Margin (Avg.)
-2.00 %

Quarterly Financial Results

Quarterly Financials
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Revenue
188
208
190
189
192
237
213
215
251
267
259
223
275
286
270
243
289
327
308
277
350
360
333
309
395
461
420
398
461
504
488
562
717
744
726
711
775
793
801
755
Expenses
109
125
112
135
114
152
128
141
162
164
159
153
170
175
190
171
189
205
203
184
223
220
210
209
269
309
286
284
297
324
311
403
470
477
477
453
496
504
543
484
EBITDA
79
83
78
54
78
86
85
75
88
103
100
70
105
111
81
72
100
122
105
93
127
141
123
100
125
151
134
114
164
180
177
160
248
267
249
258
279
289
258
270
Operating Profit %
40 %
37 %
39 %
27 %
39 %
34 %
38 %
32 %
34 %
37 %
36 %
28 %
38 %
38 %
28 %
30 %
34 %
37 %
33 %
33 %
35 %
38 %
36 %
31 %
31 %
32 %
32 %
28 %
35 %
35 %
36 %
26 %
34 %
35 %
34 %
36 %
36 %
36 %
32 %
36 %
Depreciation
5
5
6
7
5
5
7
9
7
8
10
11
12
12
13
14
10
11
11
12
15
15
17
18
23
29
30
35
41
42
46
54
76
81
81
77
71
69
70
70
Interest
0
1
0
0
0
0
3
8
7
6
5
4
1
1
0
0
0
0
0
1
1
1
1
1
7
7
3
9
17
16
18
33
60
60
57
54
49
50
49
46
Profit Before Tax
73
78
72
48
74
99
77
62
78
92
89
58
95
103
72
62
95
116
99
85
117
131
109
85
101
121
107
76
113
126
116
77
116
129
116
129
161
173
145
159
Tax
11
8
4
1
3
6
3
6
6
7
9
4
11
10
9
5
6
8
9
17
10
12
8
5
8
2
6
14
19
4
14
-3
26
33
29
27
36
38
37
-120
Net Profit
63
69
68
47
71
93
75
56
72
86
80
54
84
93
64
56
89
108
90
68
107
118
101
80
93
119
100
62
94
122
102
80
90
96
87
102
125
135
109
279
EPS in ₹
45.64
5.02
4.95
3.43
5.15
6.75
5.43
4.06
5.18
6.20
5.83
3.93
6.11
6.74
4.62
4.13
6.56
7.93
6.64
5.03
7.86
8.71
7.41
5.91
6.96
8.84
7.49
4.81
6.97
9.08
7.55
5.22
6.11
6.73
6.16
6.90
8.66
8.82
7.32
20.60
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Total Assets
398
727
1,460
1,554
1,552
1,835
2,272
3,667
7,041
7,033
7,366
Fixed Assets
65
232
771
761
875
854
918
2,568
4,319
5,307
4,447
Current Assets
237
216
299
582
480
467
627
765
2,302
1,223
1,540
Capital Work in Progress
0
0
0
3
4
2
27
22
20
67
172
Investments
144
303
365
356
78
294
520
37
16
67
437
Other Assets
190
192
324
435
595
685
807
1,041
2,686
1,593
0
Total Equity & Liabilities
398
727
1,460
1,554
1,552
1,835
2,272
3,667
7,041
7,033
7,366
Current Liabilities
71
76
226
306
165
167
200
443
2,532
1,381
2,077
Non Current Liabilities
25
60
349
79
91
91
164
1,003
1,286
2,380
1,393
Total Equity
302
591
886
1,169
1,296
1,576
1,908
2,221
3,222
3,272
3,903
Reserve & Surplus
302
553
848
1,137
1,283
1,563
1,894
2,182
2,573
2,841
3,889
Share Capital
0
14
14
14
14
14
14
14
14
14
14
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
-2
4
-8
8
-3
60
-30
14
5
38
106
Investing Activities
-92
-44
-185
-590
-5
123
-323
-320
-975
-1,828
-78
Operating Activities
90
132
200
235
223
271
375
378
292
486
1,065
Financing Activities
1
-84
-24
363
-221
-335
-82
-45
688
1,380
-881
Above figures are in Rs. Crores

Share Holding

% Holding
Jan 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Promoter
55.55 %
54.13 %
52.69 %
52.68 %
52.66 %
52.66 %
52.30 %
52.29 %
52.70 %
52.86 %
52.86 %
54.91 %
54.90 %
54.90 %
54.88 %
54.87 %
54.86 %
54.85 %
54.83 %
54.85 %
54.85 %
53.92 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
13.20 %
0.00 %
14.27 %
14.59 %
8.01 %
8.35 %
8.43 %
8.40 %
7.21 %
6.85 %
6.39 %
DIIs
10.52 %
9.25 %
9.66 %
9.57 %
9.99 %
10.11 %
10.36 %
10.38 %
9.94 %
10.02 %
10.28 %
14.53 %
13.86 %
15.63 %
16.23 %
18.64 %
18.06 %
18.07 %
18.17 %
19.36 %
20.32 %
20.35 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
22.42 %
23.28 %
23.23 %
23.29 %
23.19 %
23.14 %
21.34 %
21.27 %
21.45 %
21.66 %
22.07 %
15.47 %
15.67 %
14.24 %
13.53 %
10.51 %
9.29 %
9.16 %
9.12 %
9.12 %
8.51 %
10.06 %
Others
11.51 %
13.34 %
14.42 %
14.46 %
14.16 %
14.09 %
16.01 %
16.07 %
15.90 %
15.46 %
14.79 %
1.90 %
15.57 %
0.95 %
0.77 %
7.96 %
9.43 %
9.49 %
9.47 %
9.45 %
9.48 %
9.26 %
No of Share Holders
29,195
41,470
46,477
49,833
54,223
57,061
51,639
48,055
46,746
45,931
44,169
42,245
46,496
51,753
44,176
46,346
53,314
50,087
52,225
59,438
54,713
51,656

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 0.00 0.00 0.00 2.87 5.5 6.01 7.35 0.00 7.35 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.47 0.8 1.05 0.87 0.00 0.57 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
29 May 2026 DIVIDEND Dividend
₹ 7.21 /share
 29 May 2026 1,337.35 1,361.40
06 Aug 2021 DIVIDEND Dividend
₹ 6.01 /share
 05 Aug 2021 742.15 747.90
16 Aug 2022 DIVIDEND Dividend
₹ 7.35 /share
 11 Aug 2022 696.65 695.05
25 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
 25 Sept 2024 1,454.55 1,311.75
25 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 25 Oct 2024 1,329.15 1,283.80
04 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 04 Feb 2025 1,157.90 1,249.75
13 Feb 2025 DIVIDEND Dividend
₹ 7.35 /share
 13 Feb 2025 1,460.10 1,301.85
19 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 19 May 2025 1,402.05 1,465.15
25 Jul 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
 25 Jul 2025 1,679.60 1,785.30
05 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 05 Aug 2025 1,791.20 1,801.10
12 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 12 Nov 2025 1,599.60 1,595.20
13 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 13 Feb 2026 1,412.95 1,510.40
20 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 20 May 2026 1,373.90 1,337.35

Announcements

Announcement under Regulation 30 (LODR)-Earnings Call Transcript14 hrs ago
Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot1 day ago
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report1 day ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation1 day ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome6 days ago
Announcement under Regulation 30 (LODR)-Investor Presentation6 days ago
Announcement under Regulation 30 (LODR)-Date of payment of Dividend6 days ago
Corporate Action-Board approves Dividend6 days ago
Financial Results For The Quarter And Financial Year Ended March 31 20266 days ago
Board Meeting Outcome for Outcome Of Board Meeting6 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 15, 2026
Board Meeting Intimation for Consideration Of Financial Results And Interim DividendMay 15, 2026
Credit Rating Of Eris Threpeutics LimitedMay 12, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMay 11, 2026
Announcement under Regulation 30 (LODR)-Credit RatingMay 08, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 24, 2026
Shareholder Meeting / Postal Ballot-Notice of Postal BallotApr 23, 2026
INSPECTION OF SWISS PARENTERALS UNITS 1 AND 2 BY HALMED CROATIAApr 20, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 10, 2026
Closure Of The Transaction Related To Acquisition Of Probiotics Business Of Velbiom Probiotics Private Limited.Mar 31, 2026
Closure of Trading WindowMar 27, 2026
Corporate GuaranteeMar 27, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMar 20, 2026
Board Meeting Outcome for The Meeting Held Today I.E. March 20 2026Mar 20, 2026
Announcement under Regulation 30 (LODR)-Change in DirectorateMar 14, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 13, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMar 12, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 05, 2026
Imposition Of Fine By BSE Limited And National Stock Exchange Of India LimitedFeb 28, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 24, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 23, 2026
Corporate PresentationFeb 20, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 20, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 19, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 13, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 13, 2026
Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025Feb 13, 2026
Board Meeting Outcome for Outcome Of Board MeetingFeb 13, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 06, 2026
Board Meeting Intimation for Approval Of Financial ResultsFeb 06, 2026
Announcement under Regulation 30 (LODR)-AllotmentJan 16, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 12, 2026
Closure of Trading WindowDec 29, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportDec 26, 2025
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotDec 26, 2025
Announcement under Regulation 30 (LODR)-CessationDec 18, 2025
Second Corrigendum To The Notice Of Postal Ballot Dated November 24 2025Dec 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 15, 2025
Clarification With Respect To Increase In VolumeDec 10, 2025
Clarification sought from Eris Lifesciences LtdDec 10, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Bandhan Healthcare Fund Direct-Growth
1.61%
35273
1.61%
1.61%
The Wealth Company Small Cap Fund Direct-Growth
2.02%
8150
2.02%
2.02%
JioBlackRock Sector Rotation Fund Direct-Growth
0.00%
-514
-0.06%
-0.05%
Zerodha Nifty MidSmallcap400 50:50 Index Fund Direct-Growth
0.16%
98
0.16%
0.16%
DSP Nifty Smallcap 250 Index Fund Direct-Growth
0.37%
44
-0.04%
-0.01%
Navi Nifty Smallcap250 Momentum Quality 100 Index Fund Direct-Growth
0.60%
-17
-0.08%
-0.05%
Motilal Oswal BSE 1000 Index Fund Direct-Growth
0.04%
7
0.00%
0.01%
Navi Nifty MidSmallcap 400 Index Fund Direct-Growth
0.12%
4
-0.01%
-0.01%
DSP Nifty 500 Index Fund Direct-Growth
0.04%
2
0.00%
0.00%
JioBlackRock Nifty Smallcap 250 Index Fund Direct-Growth
0.37%
2
-0.05%
-0.02%
HDFC Business Cycle Fund Direct-Growth
1.91%
0
0.00%
-0.18%
HDFC Pharma And Healthcare Fund Direct-Growth
1.66%
0
0.00%
-0.58%
Bandhan BSE Healthcare Index Fund Direct-Growth
0.58%
0
0.00%
-0.03%
Bandhan Nifty 500 Momentum 50 Index Fund Direct-Growth
0.00%
0
0.00%
0.00%
Bandhan Nifty Smallcap 250 Index Fund Direct-Growth
0.36%
0
0.00%
-0.06%
Bandhan Nifty Total Market Index Fund Direct-Growth
0.04%
0
0.00%
0.00%
Bandhan Small Cap Fund Direct-Growth
0.30%
0
0.00%
0.02%
Bank of India Consumption Fund Direct-Growth
2.66%
0
0.00%
-0.18%
Bank of India Large & Mid Cap Fund Direct-Growth
2.05%
0
0.00%
-0.18%
Bank of India Manufacturing & Infrastructure Fund Direct-Growth
2.20%
0
0.00%
-0.32%
Bank of India Mid & Small Cap Equity & Debt Fund Direct-Growth
1.81%
0
0.00%
-0.24%
Bank of India Mid Cap Fund Direct-Growth
1.92%
0
-0.20%
-0.17%
Bank of India Midcap Tax Fund Series 1 Direct-Growth
0.98%
0
-0.13%
-0.08%
Bank of India Multi Asset Allocation Fund Direct-Growth
0.00%
0
0.00%
0.00%
Bank of India Multi Cap Fund Direct-Growth
2.28%
0
0.00%
-0.28%

Technical Indicators

RSI(14)
Neutral
49.45
ATR(14)
Less Volatile
58.71
STOCH(9,6)
Neutral
28.10
STOCH RSI(14)
Neutral
23.94
MACD(12,26)
Bearish
-0.92
ADX(14)
Weak Trend
19.83
UO(9)
Bearish
40.60
ROC(12)
Downtrend But Slowing Down
-1.78
WillR(14)
Oversold
-81.06
Bearish
4
Neutral
5
Bullish
0

About Eris Lifesciences

Eris Lifesciences Limited is an Indian company that manufactures and markets pharmaceutical products. Founded in 2007, the company operates a manufacturing plant in Guwahati, Assam. Eris focuses on chronic, sub-chronic, and acute therapeutic areas, including cardiovascular, anti-diabetics, vitamins, gastroenterology, and anti-infective. The company has a portfolio of 112 Mother Brands...more
Listing Date
29 Jun, 2017(8 Years, 28 days)
Website
https://www.eris.co.in
Chairperson NameAmit Indubhushan Bakshi
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Fundamental Screeners
Technical Screeners
Intraday Screeners
Price & Volume Screeners
Candlestick Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
Sensex Companies
Nifty 50 Companies
Nifty Next 50 Companies
Nifty Bank Companies
Finnifty Companies
Defence Stocks
Semi Conductor Stocks
Renewable Energy Stocks
AI Stocks
Cement Stocks
Penny Stocks
Multibagger Stocks
Breakout Stocks
Dividend Stocks
Large Cap Stocks
Mid Cap Stocks
Small Cap Stocks
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.
We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.
This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.
The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.
We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.
This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.
By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.
We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.

© 2025 - 2026 Raise Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai - 400104